Press release
Iron Deficiency Injectable Market Forecast 2024: Global Insights and Emerging Opportunities
Iron Deficiency Injectable Market Forecast
According to The Business Research Company's, The iron deficiency injectable market size has grown rapidly in recent years. It will grow from $12.75 billion in 2023 to $14.06 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to high prevalence of iron deficiency anemia treatments, bariatric surgery patients, pediatric and adolescent patients, growing pregnancy.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report
Market Drivers and Trends:
The increasing prevalence of polycystic ovar*y syndrome (PCOS) is expected to propel the growth of the iron deficiency injectables market going forward. Polycystic ovar*y syndrome (PCOS) is a common hormonal disorder that affects people with ovaries, primarily women of reproductive age. Polycystic ovar*y syndrome (PCOS) leads to iron overload, which results in excessive blood loss during menstruatio*n and makes patients anemic, which can be cured by injectable iron deficiency medications. For instance, in June 2023, according to the World Health Organization, a US-based specialized health agency, globally, polycystic ovar*y syndrome (PCOS) affects an estimated 8-13% of reproductive-aged women, among whom 70% remain undiagnosed. Therefore, the prevalence Of polycystic ovar*y syndrome (PCOS) is driving the growth of the iron deficiency injectables market.
Major companies operating in the iron deficiency injectables market are developing new therapies, such as INJECTAFER, to sustain their position in the market. For instance, in June 2023, Daiichi Sankyo Company, a US-based healthcare company and American Regent Inc., a US-based injectables manufacturer, launched INJECTAFER (ferric carboxymaltose injection) for iron deficiency, which the Food And Drug Administration, a US-based government agency, approved. This is the first and only intravenous iron replacement therapy for adult patients with chronic and progressive heart failure to receive FDA approval. More than 40 clinical trials involving more than 8,800 participants from different countries were examined with INJECTAFER. This latest approval builds on INJECTAFER's successful and demonstrated use in these patients, including adult and pediatric patients with iron-deficient anemia and heart failure.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample_request?id=12907&type=smp
Major Key Players of the Market:
Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH , Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.
Iron Deficiency Injectable Market 2024 Key Insights:
• The iron deficiency injectable market size is expected to grow to $20.68 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%.
• Rising Prevalence Of Pcos Fuels Demand For Iron Deficiency Injectables
• Companies Introduce Innovative Iron Deficiency Therapies Like Injectafer To Expand Market Presence
• North America was the largest region in the iron deficiency injectable market in 2023.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12907&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Iron Deficiency Injectable Market Forecast 2024: Global Insights and Emerging Opportunities here
News-ID: 3663823 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Iron
Faster Anemia Recovery: When to Switch From Iron Pills to IV Iron
Iron deficiency anemia is exhausting. When your iron is low, everyday tasks feel heavier, your focus slips, and even simple workouts become harder. Oral iron supplements are usually the first step, but they don't always work fast enough-especially if your levels are very low or your body struggles to absorb iron.
That's where IV iron becomes a more efficient option. It delivers iron directly into your bloodstream, giving your body what…
Iron Sharpens Iron Business Network Launches
The Iron Sharpens Iron Business Network has launched in Southwest Florida. The membership organization exists to drive customer referrals, social media visibility, brand exposure and business profits. Small businesses and upstarts can come together within the grass roots network and feel comfortable, not intimidated, wherever they are on their growth journey.
Membership levels can be reviewed and setup at ironsharpensironbn.com. Members of the network will have access to online educational…
Iron Warrior Review 2022: (Buyers Beware!) Is Iron Warrior Actually Working?
As you age, you begin to physically deteriorate and experience a range of challenges in daily life. You begin to feel weak and lose your physical strength after a certain age, among other things.
You start to experience problems in both your personal and professional lives, and you constantly feel exhausted.
Even though frequenting the gym might help you stay in shape, given today's busy lifestyle and competitive job market,…
Global Carbonyl Iron Market, Global Carbonyl Iron Industry, Covid-19 Impact Glob …
Carbonyl iron is an iron replacement product. You primarily get the iron from the foods you eat. Iron assists your body introduce red blood cells that carry oxygen through your blood to tissues and organs. Carbonyl iron is utilized to cure and safeguard the iron deficiency and iron deficiency anemia. In addition, the carbonyl iron may also be utilized for the determinations not listed in this medication guide.
According to…
Iron Ore Concentrate (Pellet Feed) Market forecast to 2025: Exceptional Business …
Report Ocean recently published a new report on the Global Iron Ore Concentrate (Pellet Feed) Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Iron Ore Concentrate (Pellet Feed) Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Iron Ore Concentrate (Pellet Feed) Market situation of…
Global Iron Ore Mining Market to 2022| Vale S.A., Rio Tinto Group, BHP Billiton, …
Researchmoz added Most up-to-date research on "Global Iron Ore Mining to 2022" to its huge collection of research reports.
GlobalData's "Global Iron Ore Mining to 2022" provides a comprehensive coverage on global iron ore industry. It provides historical and forecast data on iron ore production by country, grade, iron ore reserves, consumption to 2022. The trade section also provides information on major exporters and importers. The report also includes a demand…
